School of Pharmacy Publications

Browse Results (4118 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 54 of 83

Result Pages:    « first ‹ previous  44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Rostam, Muhamad A., Piva, Terrence J., Rezaei, Hossein B., Kamato, Danielle, Little, Peter J., Zheng, Wenhua and Osman, Narin (2015) Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 42 2: 117-124. doi:10.1111/1440-1681.12335 11   4 Cited 5 times in Scopus5 1
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. In: Abstracts : Fourth Canadian Therapeutics Congress. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, (e152-e152). 27-30 May 2007. 23  
Barozzi, N. and Tett, S. E. (2009) Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 5: 509-519. doi:10.1007/s10067-008-1077-8 72   7 Cited 11 times in Scopus11 0
Hasan, Syed Shahzad, Wong. Pei Se, Ahmed, Syed Imran, Chong, David Weng Kwai, Mai, Chun Wai, Pook, Peter and Kairuz, Therese (2013) Perceived impact of clinical placements on students' preparedness to provide patient-centered care in Malaysia. Currents in Pharmacy Teaching and Learning, 5 4: 303-310. doi:10.1016/j.cptl.2013.01.010 62   0 0
Poudel, Arjun, Khanal, Saval, Alam, Kadir and Palaian, Subish (2009) Perception Of Nepalese Community Pharmacists Towards Patient Counseling And Continuing Pharmacy Education Program: A Multicentric Study. Journal of Clinical and Diagnostic Research, 3 2: 1408-1413.    
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008) Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Clinical Therapeutics, 30 12: 2461-2473. doi:10.1016/j.clinthera.2008.12.016 119   8 Cited 10 times in Scopus10 0
Babar, Muneer Gohar, Syed, Shahzad Hasan, Naing, Cho Min and Hamzah, Nur Hidayah Binti (2012) Perceptions and self-use of Complementary and Alternative Medicine (CAM) among Malaysian dental students. European Journal of Integrative Medicine, 4 1: E63-E69. doi:10.1016/j.eujim.2011.11.001 41   2 Cited 6 times in Scopus6 0
Bajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004) Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 3: 221-234. doi:10.1111/j.1369-7625.2004.00280.x 151   24 Cited 33 times in Scopus33 0
Bajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. In: Maria Cordina, Social Pharmacy: Exploring theoretical and cultural perspectives. 13th International Social Pharmacy Workshop, Malta, (64-64). 19-23 July, 2004. 65  
Bajramovic Fejzic, Jasmina, Emmerton, Lynne and Tett, Susan (2004). Perceptions of concordance with medicines: focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. In: 13th International Social Pharmacy Workshop, Valetta, Malta, (). 19-23 July 2004.    
Kairuz, Therese, Case, Sarah and Shaw, John (2007) Perceptions of graduates and preceptors regarding a new pharmacy programme. Pharmacy Education, 7 2: 151-157. doi:10.1080/15602210701275864 37   Cited 6 times in Scopus6 0
Cottrell, N., Emmerton, L. and Denaro, C. (2010). Perceptions of heart failure patients towards non-steroidal anti-inflammatory drugs. In: Abstract of the National Medicines Sympsium 2010: Medicines in people‚Äôs lives.. National Medicines Symposium 2010, Melbourne, VIC, Australia, (235-235). 26-28 May, 2010. 41  
Hall, Kristine B., Tett, Susan E. and Nissen, Lisa M. (2006) Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Medical Care, 44 4: 383-387. doi:10.1097/01.mlr.0000204017.71426.53 175   21 Cited 22 times in Scopus22 0
Monteith, G. R. (1999) Performance enhancing drugs. Australian Pharmacist, 18 11: 654-658. 74  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina patients. In: K. Brosen, O.A. Medergaard and M. Orme, Clinical pharmacology - from molecule to society - bridging the gap via man. 5th Congress of European Assoc. for Clinical Pharmacology &Therapeutics, Odense, Denmark, (83-83). 12-15 Sept 2001. 93  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina using retrospective routine therapeutic drug monitoring data. In: S.J. Soldin and F. Sjoqvist, Abstracts - 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology. 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Washington DC, (493-493). 1-6 Sept 2001. 72  
Steer, P., Flenady, V., Gray, P., Shearman, A. D. and Charles, B. G. (2000). Periextubation caffeine for neonates born less than 30 weeks gestation: a randomised trial of two dosing regimens. In: Proceedings of 4th annual congress of Perinatal Society of Australia & New Zealand. 4th Annual Congress of PSANZ, Brisbane, Qld, Australia, (75-75). 12-15 March 2000. 75  
Steer, P.A., Flenady, V.J., Gray, P.H., Shearman, A.D., Henderson-Smart, D., Fraser, S., Bury, G. and Charles, B.G. (2000). Periextubation caffeine in neonates born less than 30 weeks gestation: A randomised trial of two dosing regimens. In: Unknown. Unknown, Unknown, (434A-434A). Unknown. 31   0
Steer, P. A., Flenady, V. J., Shearman, A., Lee, T. C., Tudehope, D. I. and Charles, B. G. (2003) Periextubation caffeine in preterm neonates: A randomized dose response trial. Journal of Paediatrics And Child Health, 39 7: 511-515. doi:10.1046/j.1440-1754.2003.00207.x 118   16 Cited 24 times in Scopus24 0
Hale, A. R., Coombes, I. D., Stokes, J., McDougall, D., Whitfield, K., Maycock, E. and Nissen, L. (2013) Perioperative medication management: Expanding the role of the preadmission clinic pharmacist in a single centre, randomised controlled trial of collaborative prescribing. BMJ Open, 3 7: . doi:10.1136/bmjopen-2013-003027 27   5 Cited 9 times in Scopus9 24
Sturgess D (2016). Perioperative opioids and tumour growth and metastasis. In: Australian and New Zealand College of Anaesthetists Annual Scientific Meeting, Auckland NZ, (). 30 April - 4 May 2016.    
Smith B, Kostner K, Presneill P, Dennis A, Davies K, Cramp P, Paxton J and Sturgess D (2014). Perioperative Transthoracic Echocardiography in High Risk Obstetric Patients. In: Australian and New Zealand College of Anaesthetists Annual Scientific Meeting, Singapore, (). 5-9 May 2014.    
Rahiman, Fazalul S. S., Morgan, M., Gray, P., Shaw, P. and Cabot, P. (2016). Peripheral kappa-opioid receptor (KOR) stimulation exerts anti-inflammatory effects in lipopolysaccharide (LPS)-activated macrophages. In: ICI 2016 International Congress of Immunology. ICI 2016 International Congress of Immunology, Melbourne, VIC, Australia, (399-399). 21-26 August 2016. doi:10.1002/eji.201670200     0 0
Varamini, Pegah, Goh, Wei Huang, Mansfeld, Friederike M., Blanchfield, Joanne T., Wyse, Bruce D., Smith, Maree T. and Toth, Istvan (2013) Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. Bioorganic & Medicinal Chemistry, 21 7: 1898-1904. doi:10.1016/j.bmc.2013.01.044 69   10 Cited 12 times in Scopus12 0
Faddy, H. M., Robinson, J. A., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Peroxisome proliferator-activated receptor a in human breast cancer cell lines. In: Building a healthier future through research. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, (264-264). 30 November - 1 December, 2004. 54  
Suchanek, K. M., Lee, W. J., May, F. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2001). Peroxisome proliferator-activated receptor alpha and beta characterization in human mammary gland epithelial cell lines. In: International Congress of Toxicology, Brisbane Australia, (93-93). 8-13 July 2001. 45   0
Faddy, H. M., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2006) Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate. International Journal of Biochemistry & Cell Biology, 38 2: 255-266. doi:10.1016/j.biocel.2005.09.002 84   16 Cited 14 times in Scopus14 0
Suchanek, Kate M., May, Fiona J., Robinson, Jodie A., Lee, Won Jae, Holman, Nicola A., Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2002) Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Molecular Carcinogenesis, 34 4: 165-171. doi:10.1002/mc.10061 90   88 Cited 92 times in Scopus92 0
Jeffery, B, Choudhury, AI, Horley, N, Bruce, M, Tomlinson, SR, Roberts, RA, Gray, TJB, Barrett, DA, Shaw, PN, Kendall, D and Bell, DR (2004) Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver. Archives of Biochemistry And Biophysics, 429 2: 231-236. doi:10.1016/j.abb.2004.06.025 75   12 Cited 11 times in Scopus11 0
Suchanek, K. M., May, F. J., Lee, W. J., Holman, N. A. and Roberts-Thomson, S. J. (2002) Peroxisome proliferator-activated receptor beta expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin. International Journal of Biochemistry & Cell Biology, 34 9: 1051-1058. doi:10.1016/S1357-2725(02)00025-0 54   26 Cited 25 times in Scopus25 0
Falconer, Caitlin, Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2009). Peroxisome proliferator-activated receptor expression in the mouse mammary gland and human breast cancer cell lines. In: ASCEPT 43rd Annual Scientific Meeting 2009: The Rights of Medicines, Darling Harbour, NSW, Australia, (). 29 November-2 December 2009. 28  
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE). In: Neuroscience 2006. Neuroscience 2006, Georgia World Congress Center / Altana, Georgia, U.S.A., (). 11-18 October, 2006. 79  
Lister, E. J., Faddy, H. M., Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2005). Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells. In: E. A. Davis and C. G. Sobey, Program & Abstracts: Joint Meeting of ASCEPT and APSA 2005. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, (1-79-1-79). 4-7 December, 2005. 68  
Little, P. J., Topliss, D. J., Mudaliar, S. and Law, R. E. (2004). Peroxisome Proliferator-Activated Receptors and diabetic vasculature. In Diabetes and Cardiovascular Disease: Integrating Science and Clinical Medicine (pp. 75-91) Philadelphia USA: LWW.    
Smith, S. A., Monteith, G. R. and Roberts-Thomson, S. J. (2002). Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures. In: Proceedings of the Society for Neuroscience 2002. Neuroscience 2002, Florida, (493-493). 2-7 Nov. 2002. 46  
Roberts-Thomson, S. J. (2000) Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumour promotion and treatment. Immunology And Cell Biology, 78 4: 436-441. doi:10.1046/j.1440-1711.2000.00921.x 63   62 Cited 72 times in Scopus72 0
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptors modulate inflammation in relapsing-remitting experimental autoimmune encephalomyelitis. In: Combined Conference Abstracts: ComBio 2006. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, (178-178). 24-28 September, 2006. 52  
Roberts-Thomson, S. J., Robinson, J. A., Faddy, H. M., Holman, N. A., Davis, B.J., Gopisetty Venkata, N., Suchanek, K. M., May, F. J., Lee, W. J. and Monteith, G. R. (2003). Peroxisome proliferator-activated receptors (PPAR) and breast cancer. In: Annual Queensland Health & Medical Scientific Meeting. Annual Queensland Health & Medical Scientific Meeting 2003, Brisbane, Qld, Australia, (1-1). 25-26 November, 2003. 79  
Tan, Amy, Emmerton, Lynne and Hattingh, Laetitia (2012) Personal carers' role in medication administration: An exploratory study in a rural community in Queensland. The Australian Nursing Journal, 19 10: 31-31. 120 2 0
Kairuz, T. E., Crump, K. and O'Brien, A. (2007) Perspectives on qualitative research. Part 2: Useful tools for data collection and analysis. The Pharmaceutical Journal, 278 7445: 371-372. 115  
Dredge, K, Hammond, E, Handley, P, Gonda, TJ, Smith, MT, Vincent, C, Brandt, R, Ferro, V and Bytheway, I (2011) PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. British Journal of Cancer, 104 5: 635-642. doi:10.1038/bjc.2011.11 142   63 Cited 67 times in Scopus67 0
Chan, H. Y. H., Nissen, Lisa M., Hollingworth, Samantha A. and Steadman, Kathryn (2011). Pharmaceutical access in Australia, Hong Kong, Thailand, Vietnam, Singapore and Malaysia. In: Australasian Pharmaceutical Science Association (APSA) 2011, Adelaide, Australia, (). 11-14 December 2011. 60  
Emmerton, L. and Shaw, J. P. (1995) Pharmaceutical care: from theory to practice. New Zealand Pharmacy Journal, 15 7: 20-23. 24  
Shaw, J., Emmerton, L., Kheir, N. A., Barron, P. A., Becket, G. and Smith, N. A. (2000). Pharmaceutical care of asthma patients in a New Zealand community pharmacy setting. In: 137th British Pharmaceutical Conference, Birmingham, UK, (). September 10-13 2000. 89  
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008) Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. Journal of Clinical Pharmacy and Therapeutics, 33 5: 553-559. doi:10.1111/j.1365-2710.2008.00948.x 80   1 Cited 4 times in Scopus4 0
Coombes, I., Hall, A., Maclean, C. and Mitchell, C. (2006) Pharmaceutical review-Queensland Health's experience. Journal of Pharmacy Practice and Research, 36 4: 256-259. 186   0
Poulson, LK, Nissen, L and Coombes, I (2010) Pharmaceutical review using telemedicine: A before and after feasibility study. Journal of Telemedicine and Telecare, 16 2: 95-99. doi:10.1258/jtt.2009.090716 115   8 Cited 6 times in Scopus6 0
Nguyen, Thi-My-Uyen, Lau, Esther T. L., Steadman, Kathryn J., Cichero, Julie A.Y., Dingle, Kaeleen and Nissen, Lisa M. (2014) Pharmacist, general practitioner, and nurse perceptions, experiences, and knowledge of medication dosage form modification. Integrated Pharmacy Research and Practice, 3 1-9. doi:10.2147/IPRP.S53797 74   2
Freeman, Chris (2014) Pharmacist in general practice: pharmacist and the GP. Australian Journal of Pharmacy, 95 1124: 12-12. 27  
Jones, A., Kairuz, T., Nissen, L. M. and Steadman, K. (2009). Pharmacist practice and student experience of extemporaneous compounding in Queensland. In: S. Aldous, G. Peterson, G. Jacobson and L. Bereznicki, Australasian Pharmaceutical Science Association Annual Conference 2009 : Program and Abstracts. Out of the Wilderness: Australasian Pharmaceutical Science Association Annual Conference, Hobart, Tas, Australia, (143-143). 8-11 December, 2009. 81  

Page 54 of 83

Result Pages:    « first ‹ previous  44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63  next › last »